Table 3.
Correlations Between Whole Blood Cannabinoid Levels and Pharmacodynamic Outcomes.
| THC | 11-OH-THC | THCCOOH | |
|---|---|---|---|
| 10 mg | |||
| VAS Drug Effect | 0.44** | 0.58** | 0.40** |
| DAT Distance from Target | 0.40** | 0.40** | 0.39** |
| DSST % Correct | −0.12 | −0.14 | −0.11 |
| PASAT Total Correct | −0.29** | −0.33** | −0.31** |
| 25 mg | |||
| VAS Drug Effect | 0.60** | 0.62** | 0.67** |
| DAT Distance from Target | 0.26** | 0.26** | 0.45** |
| DSST % Correct | −0.21** | −0.32** | −0.43** |
| PASAT Total Correct | −0.24** | −0.33** | −0.42** |
| 50 mg | |||
| VAS Drug Effect | 0.45** | 0.49** | 0.38** |
| DAT Distance from Target | 0.32** | 0.49** | 0.67** |
| DSST % Correct | −0.36** | −0.43** | −0.40** |
| PASAT Total Correct | −0.32** | −0.54** | −0.62** |
Correlation is significant at the 0.01 level (two-tailed).